-
A648071-1mgAuriculasin is a nature product isolated from Limonium leptophyllum . Auriculasin has activity toward cannabinoid receptor type 1 (CB1) with an IC 50 value of 8.92 µMForm:SolidIC50&: Target:CB1 8.92 μM (IC 50 ).
-
A649679-10mgAurora kinase inhibitor-8 is a highly selective inhibitor of the Aurora kinases .Form:Solid.
-
A649679-5mgAurora kinase inhibitor-8 is a highly selective inhibitor of the Aurora kinases .Form:Solid.
-
A647222-100mgAutotaxin modulator 1 is an autotaxin (ATX) enzyme inhibitor, extracted from patent WO 2014018881 A1, Compound Example 12b. Autotaxin modulator 1 is expected to be useful for researching demyelination due to injury or disease, as well as for
-
A647222-10mgAutotaxin modulator 1 is an autotaxin (ATX) enzyme inhibitor, extracted from patent WO 2014018881 A1, Compound Example 12b. Autotaxin modulator 1 is expected to be useful for researching demyelination due to injury or disease, as well as for
-
A647222-50mgAutotaxin modulator 1 is an autotaxin (ATX) enzyme inhibitor, extracted from patent WO 2014018881 A1, Compound Example 12b. Autotaxin modulator 1 is expected to be useful for researching demyelination due to injury or disease, as well as for
-
A647222-5mgAutotaxin modulator 1 is an autotaxin (ATX) enzyme inhibitor, extracted from patent WO 2014018881 A1, Compound Example 12b. Autotaxin modulator 1 is expected to be useful for researching demyelination due to injury or disease, as well as for
-
A654927-1mlAutotaxin modulator 1 is an autotaxin (ATX) enzyme inhibitor, extracted from patent WO 2014018881 A1, Compound Example 12b. Autotaxin modulator 1 is expected to be useful for researching demyelination due to injury or disease, as well as for
-
A650874-100mgAutotaxin-IN-3 is a Autotaxin(ATX) inhibitor with an IC 50 of 2.4 nM, compound 33, sourced from patent WO2018212534A1In VitroAutotaxin is an enzyme which is responsible for the increase in lysophosphatidic acid in ascites and plasma, and it is a
-
A650874-10mgAutotaxin-IN-3 is a Autotaxin(ATX) inhibitor with an IC 50 of 2.4 nM, compound 33, sourced from patent WO2018212534A1In VitroAutotaxin is an enzyme which is responsible for the increase in lysophosphatidic acid in ascites and plasma, and it is a
-
A650874-50mgAutotaxin-IN-3 is a Autotaxin(ATX) inhibitor with an IC 50 of 2.4 nM, compound 33, sourced from patent WO2018212534A1In VitroAutotaxin is an enzyme which is responsible for the increase in lysophosphatidic acid in ascites and plasma, and it is a
-
A650874-5mgAutotaxin-IN-3 is a Autotaxin(ATX) inhibitor with an IC 50 of 2.4 nM, compound 33, sourced from patent WO2018212534A1In VitroAutotaxin is an enzyme which is responsible for the increase in lysophosphatidic acid in ascites and plasma, and it is a